MP23-05 ASSESSMENT OF PATIENT PERSPECTIVE ON BENEFIT AND RISK (B-R) ASSOCIATED WITH HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) FOR THE ABLATION OF PROSTATE TISSUE IN MEN WITH LOCALIZED PROSTATE CANCER

INTRODUCTION AND OBJECTIVE:The FDA cleared HIFU for prostate tissue ablation in 2015. This study aims to explore patient preferences regarding the known benefit and important adverse events associa...